Skip to main content
TipRanks
Go Ultimate75% OFF

Luxbright AB (LUR0) AI Stock Analysis

0 Followers
DE:LUR0

Luxbright AB

(Frankfurt:LUR0)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Low LeverageMinimal debt and low leverage reduce financial pressure and preserve flexibility during the company’s development phase. A sizable equity cushion can help absorb operating losses and gives management more room to fund commercialization without the immediate burden of substantial interest or refinancing obligations.
Negative Factors
Persistent LossesLarge, persistent net losses and deeply negative operating results show that current revenue has not yet supported a profitable operating model. Continued losses can consume the company’s equity resources, delay self-funded growth, and make successful commercialization essential to improving long-term financial sustainability.

Luxbright AB (LUR0) vs. iShares MSCI Germany ETF (EWG)

-100%-75%-50%-25%0%25%DE:LUR0-91.77%EWG+9.20%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 1.28M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-0.4
Beta (1Y)
-0.53
Revenue Growth
-10.74%
EPS Growth
1.57%
Country
Germany
Employees
11
Sector
Healthcare
Sector Strength
51
Industry
Medical - Devices

Luxbright AB Business Overview & Revenue Model

Company Description

Luxbright AB (publ), a technology-driven enterprise headquartered in Gothenburg, Sweden, specializes in engineering and marketing X-ray tubes, generators, and comprehensive X-ray systems. Established in 2012, the company's primary focus is on providi...

Luxbright AB Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:LUR0 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SE:PAXSE:PAX60NeutralSEK 1.54B-302.47-1.22%―34.05%-144.96%
SE:BACTI.BSE:BACTI.B53NeutralSEK 523.91M83.061.93%―-0.51%―
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SE:SDOSSE:SDOS46NeutralSEK 29.93M-3.43――-19.44%-475.48%
SE:SCIBSE:SCIB40UnderperformSEK 128.49M-0.68-415.20%―54.94%47.64%
SE:SPECSE:SPEC40UnderperformSEK 20.68M-0.12-57.15%――78.15%

* Healthcare Sector Average

Performance Comparison

-50%0%50%100%DE:LUR0SE:PAXSE:SCIBSE:SPECSE:BACTI.BSE:SDOSDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:LUR0 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:LUR0Luxbright AB0.43-4.83-91.89%
SE:PAXPaxman AB66.004.006.45%
SE:SCIBSciBase Holding AB9.10-11.82-56.50%
SE:SPECSpectraCure AB0.01-0.12-89.55%
SE:BACTI.BBactiguard Holding AB14.95-1.05-6.56%
SE:SDOSScandiDos AB0.42-0.63-60.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.